User profiles for Juan Enghelmayer
Juan Ignacio EnghelmayerHospital de Clínicas, Buenos Aires University. Argentina Verified email at funef.org Cited by 179 |
[HTML][HTML] Role of imaging in progressive-fibrosing interstitial lung diseases
SLF Walsh, A Devaraj, JI Enghelmayer… - European …, 2018 - Eur Respiratory Soc
Imaging techniques are an essential component of the diagnostic process for interstitial
lung diseases (ILDs). Chest radiography is frequently the initial indicator of an ILD, and …
lung diseases (ILDs). Chest radiography is frequently the initial indicator of an ILD, and …
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study
…, J Goldin, JB Seo, J Enghelmayer… - The Lancet …, 2023 - thelancet.com
One view of sarcoidosis is that the term covers many different diseases. However, no
classification framework exists for the future exploration of pathogenetic pathways, genetic or …
classification framework exists for the future exploration of pathogenetic pathways, genetic or …
Idiopathic pulmonary fibrosis is associated with common genetic variants and limited rare variants
…, Y Zhang, CMA Prele, JI Enghelmayer… - American journal of …, 2023 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a rare, irreversible, and progressive
disease of the lungs. Common genetic variants, in addition to nongenetic factors, have been …
disease of the lungs. Common genetic variants, in addition to nongenetic factors, have been …
Latin American Registry of Idiopathic Pulmonary Fibrosis (REFIPI): clinical characteristics, evolution and treatment
…, MJD Verduzco, I De la Fuente, JI Enghelmayer… - Archivos de …, 2022 - Elsevier
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible and frequently
fatal disease. Currently there are national and multinational registries in Europe, United …
fatal disease. Currently there are national and multinational registries in Europe, United …
Description of a single centre cohort of patients with systemic sclerosis from the University Hospital of Buenos Aires and factors associated with lung function …
JI Enghelmayer, MJL Meiller, A Vallejos, F Felder… - Reumatología …, 2023 - Elsevier
Introduction Given the paucity of data in Latin America and especially in Argentina regarding
the epidemiology of SSc, the prevalence of ILD, its course, and particularly the response to …
the epidemiology of SSc, the prevalence of ILD, its course, and particularly the response to …
Real-life experience with Pirfenidone in idiopathic pulmonary fibrosis in Argentina. A Retrospective Multicenter Study
FM Caro, ML Alberti, F Campins, JI Enghelmayer… - Archivos de …, 2019 - Elsevier
Introduction Pirfenidone was the first antifibrotic drug approved in Argentina for idiopathic
pulmonary fibrosis (IPF). Outcomes in real life may differ from the results of clinical trials. The …
pulmonary fibrosis (IPF). Outcomes in real life may differ from the results of clinical trials. The …
[HTML][HTML] Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies
…, M García-Moyano, JI Enghelmayer… - Seminars in Arthritis and …, 2023 - Elsevier
Objective To compare the efficacy, toxicity and glucocorticoid (GC)-sparing effects of intravenous
cyclophosphamide (iv CYC) with other immunosuppressive regimes as the induction …
cyclophosphamide (iv CYC) with other immunosuppressive regimes as the induction …
Shrinking lung syndrome in systemic lupus erythematosus: A study of 9 patients
A Casey, JI Enghelmayer, CG Legarreta… - … Clínica (English Edition), 2024 - Elsevier
Introduction Shrinking Lung Syndrome (SLS) is a rare manifestation of systemic lupus
erythematosus. Our aim was to describe the clinical, radiological, and functional characteristics of …
erythematosus. Our aim was to describe the clinical, radiological, and functional characteristics of …
[HTML][HTML] Comparing transbronchial cryobiopsy and surgical biopsy in idiopathic pulmonary fibrosis
S Quadrelli, JI Enghelmayer, M Otaola… - American Journal of …, 2019 - atsjournals.org
In 2018, the Fleischner Society (1) and American Thoracic Society/European Respiratory
Society/Japanese Respiratory Society/Latin American Thoracic Association (2) guidelines for …
Society/Japanese Respiratory Society/Latin American Thoracic Association (2) guidelines for …
Can Clinical Guidelines on Idiopathic Pulmonary Fibrosis be Applied in Ibero-America? The Need to Establish Centers of Reference.
D Castillo, JI Enghelmayer - Archivos de bronconeumologia, 2019 - europepmc.org
… Enghelmayer JI 2 …